株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心調律管理装置の世界市場:製品、地域別 - 規模、シェア、動向、およびセグメント予測(2019年~2026年)

Cardiac Rhythm Management Devices Market Size, Share & Trend Analysis Report By Product (Pacemaker, Defibrillators, & CRT Devices) And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 614697
出版日 ページ情報 英文 107 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.06円で換算しております。
Back to Top
心調律管理装置の世界市場:製品、地域別 - 規模、シェア、動向、およびセグメント予測(2019年~2026年) Cardiac Rhythm Management Devices Market Size, Share & Trend Analysis Report By Product (Pacemaker, Defibrillators, & CRT Devices) And Segment Forecasts, 2019 - 2026
出版日: 2019年11月12日 ページ情報: 英文 107 Pages
概要

世界の心調律管理装置市場は、2019年から2026年の間に7.1%のCAGRで成長する見通しで、2026年には327億米ドルに達すると予測されています。

当レポートは世界の心調律管理装置市場について調査しており、市場の動向や見通し、製品・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査方法および範囲

  • 市場セグメント・範囲
  • 調査方法
  • 情報調達
  • 情報/データ分析
  • 市場の策定と検証
  • 調査方法の詳細
  • 二次資料のリスト
  • 一次資料のリスト
  • 調査の目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し

第3章 市場変数、動向、および範囲

  • 市場力学
  • 市場分析ツール

第4章 市場分析:製品別

  • 定義・範囲
  • 市場シェア分析
  • 世界市場
  • 市場規模、予測、動向分析

第5章 市場分析:地域別

  • 定義・範囲
  • 市場のスナップショット
  • 市場規模・予測、取引量・動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 企業プロファイル
  • Physio-Control, Inc. (Stryker)
  • Schiller
  • Medtronic
  • St Jude Medical (Abbott)
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Zoll Medical Corporation
  • BIOTRONIK
図表

List of Tables

  • Table 1 Primary interview details: North America
  • Table 2 Primary interview details: Europe
  • Table 3 Primary interview details: Asia Pacific
  • Table 4 Primary interview details: Latin America
  • Table 5 Primary interview details: Middle East and Africa
  • Table 6 List of secondary sources
  • Table 7 Technological trends in CRM Devices
  • Table 8 Recently approved AEDs

List of Figures

  • Fig. 1 CRM Devices Segmentation and Scope
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews in North America
  • Fig. 6 Primary interviews in Europe
  • Fig. 7 Primary interviews in Asia Pacific
  • Fig. 8 Primary interviews in Latin America
  • Fig. 9 Primary interviews in Middle East and Africa
  • Fig. 10 Market research approaches
  • Fig. 11 Value-chain-based sizing & forecasting
  • Fig. 12 QFD modeling for market share assessment
  • Fig. 13 Market formulation & validation
  • Fig. 14 Commodity flow analysis
  • Fig. 15 Volume price analysis
  • Fig. 16 Market outlook (2018)
  • Fig. 17 Segment outlook
  • Fig. 18 Market driver relevance analysis (Current & future impact)
  • Fig. 19 CVD prevalence in U.S. (%)
  • Fig. 20 CVD prevalence in U.S. by cardiac diseases (percentage, %)
  • Fig. 21 Geriatric population (million)
  • Fig. 22 Market restraint relevance analysis (Current & future impact)
  • Fig. 23 Porter's five forces analysis
  • Fig. 24 PESTLE analysis
  • Fig. 25 Strategy mapping
  • Fig. 26 CRM Devices market: Product movement analysis
  • Fig. 27 CRM Devices market product outlook: Key takeaways
  • Fig. 28 Pacemaker, 2014 - 2026 (USD million)
  • Fig. 29 Implantable pacemaker, 2014 - 2026 (USD million)
  • Fig. 30 External pacemaker, 2014 - 2026 (USD million)
  • Fig. 31 Defibrillators, 2014 - 2026 (USD million)
  • Fig. 32 ICDs, 2014 - 2026 (USD million)
  • Fig. 33 S-ICD, 2014 - 2026 (USD million)
  • Fig. 34 T-ICD, 2014 - 2026 (USD million)
  • Fig. 35 External defibrillators, 2014 - 2026 (USD million)
  • Fig. 36 Manual external defibrillators, 2014 - 2026 (USD million)
  • Fig. 37 Automatic external defibrillators, 2014 - 2026 (USD million)
  • Fig. 38 Wearable cardioverter defibrillators, 2014 - 2026 (USD million)
  • Fig. 39 CRT, 2014 - 2026 (USD million)
  • Fig. 40 CRT pacemaker, 2014 - 2026 (USD million)
  • Fig. 41 CRT defibrillators, 2014 - 2026 (USD million)
  • Fig. 42 CRM Devices market: Regional movement analysis
  • Fig. 43 Regional market place: Key takeaways
  • Fig. 44 North America CRM Devices market, by country, 2014 - 2026 (USD Million)
  • Fig. 45 U.S. CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 46 Canada CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 47 Europe CRM Devices market, by country, 2014 - 2026 (USD Million)
  • Fig. 48 UK. CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 49 Germany CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 50 France CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 51 Italy CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 52 Spain CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 53 Asia Pacific CRM Devices market, by country, 2014 - 2026 (USD Million)
  • Fig. 54 Japan implantation CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 55 China CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 56 Australia CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 57 India CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 58 Latin America CRM Devices market, by country, 2014 - 2026 (USD Million)
  • Fig. 59 Brazil CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 60 Mexico CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 61 MEA CRM Devices market, by country, 2014 - 2026 (USD Million)
  • Fig. 62 South Africa CRM Devices market, 2014 - 2026 (USD Million)
  • Fig. 63 Saudi Arabia CRM Devices market, 2014 - 2026 (USD Million)
目次
Product Code: GVR-2-68038-315-7

The global cardiac rhythm management devices market size is anticipated to reach USD 32.7 billion by 2026, is expected to grow at a CAGR of 7.1% during the forecast period as per the new report by Grand View Research, Inc. The cardiac rhythm management (CRM) devices market has shown a constant growth in the adoption of CRM devices owing to the increasing prevalence of cardiovascular disorders. Stroke and ischemic heart disease account for more than 80% of all deaths related to CVD worldwide. According to CDC in 2017, CVDs are responsible for about 800,000 lives lost in the U.S.

Favorable reimbursement policies, by the U.S. Medicare system, for biventricular pacemakers, single chamber, and dual chamber is further anticipated to increase adoption of these devices in future. Revolutionary technological progresses are rapidly transforming the cardiac rhythm management market. Major CRM devices market players operational are Physio-Control, Inc. (Stryker), Medtronic, St. Jude Medical, Boston Scientific Corporation etc. which account for a significant share of the market owing to their extensive product offerings. Industry players are further focusing on increasing their foothold by collaborations and acquisitions. For ex. in March 2019, Zoll acquired Golden Hour Data Systems to optimize its operations with complete suite of business solutions.

Further Key Findings From the Study Suggest:

  • Defibrillators held the dominant share due to high acceptance of these products in countries such as the U.S., China, and India. The ICD segment was the largest sub segment in 2018, accounting for over 70.00% of the market share, owing to its better patient outcome.
  • Within external defibrillator segment, manual external defibrillator held the highest share in 2018 as manual defibrillators have capabilities that AEDs do not possess, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat.
  • Physio-Control, Inc. (Stryker), Medtronic, St. Jude Medical, Boston Scientific Corporation are some of the major CRM devices market participants due to their product offerings and regional presence
  • Companies are adopting different strategies to gain competitive advantage. New product development, partnerships, mergers & acquisitions, strategic collaborations, and regional penetration are some of them.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Products
    • 1.1.2 Region
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
      • 1.3.5.1 Data for primary interviews in North america
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume price analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 CRM Devices Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing incidence of cardiac disorders
      • 3.1.1.2 Favorable reimbursement policies
      • 3.1.1.3 Growing geriatric population base
      • 3.1.1.4 Growing adoption of sedentary lifestyle
      • 3.1.1.5 Market Restrain Analysis
      • 3.1.1.6 Stringent regulatory framework
  • 3.2 CRM Devices: Market Analysis Tools
    • 3.2.1 Industry Analysis - PORTER'S
    • 3.2.2 SWOT Analysis By Factors (political & legal, economic and technological)
    • 3.2.3 Major Deals And Strategic Alliances
    • 3.2.4 Cardiac Practices In U.S.
      • 3.2.4.1 Product Recalls

Chapter 4 CRM Devices Market: Segment Analysis, by Product, 2014 - 2026 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Product Type Market Share Analysis, 2018 & 2026
  • 4.3 Global CRM Devices Market, by Product, 2014 to 2026
  • 4.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026
    • 4.4.1 Pacemaker
      • 4.4.1.1 Pacemaker, 2014 - 2026 (USD Million)
    • 4.4.2 Implantable Pacemaker
      • 4.4.2.1 implantable Pacemaker, 2014 - 2026 (USD Million)
    • 4.4.3 External Pacemaker
      • 4.4.3.1 External Pacemaker, 2014 - 2026 (USD Million)
    • 4.4.4 Defibrillators
      • 4.4.4.1 Defibrillators, 2014 - 2026 (USD Million)
      • 4.4.4.2 ICDs
      • 4.4.4.2.1 ICDs, 2014 - 2026 (USD Million)
      • 4.4.4.2.2 s-ICD
      • 4.4.4.2.2.1 s-ICD, 2014 - 2026 (USD Million)
      • 4.4.4.2.3 T-ICD
      • 4.4.4.2.3.1 T-ICD, 2014 - 2026 (USD Million)
      • 4.4.4.3 External Defibrillators
      • 4.4.4.3.1 External Defibrillators, 2014 - 2026 (USD Million)
      • 4.4.4.3.2 Manual External Defibrillators
      • 4.4.4.3.2.1 Manual External Defibrillators, 2014 - 2026 (USD Million)
      • 4.4.4.3.3 Automatic External Defibrillators (AED)
      • 4.4.4.3.3.1 Automatic External Defibrillators, 2014 - 2026 (USD Million)
      • 4.4.4.3.4 Wearable Cardioverter Defibrillators (WCD)
      • 4.4.4.3.4.1 Wearable Cardioverter Defibrillators, 2014 - 2026 (USD Million)
    • 4.4.5 CRT
      • 4.4.5.1 CRT, 2014 - 2026 (USD Million)
      • 4.4.5.2 CRT pacemaker
      • 4.4.5.2.1 CRT pacemaker, 2014 - 2026 (USD Million)
      • 4.4.5.3 CRT- Defibrillators
      • 4.4.5.3.1 CRT-deffibrillators, 2014 - 2026 (USD Million)

Chapter 5 CRM Devices Market: Regional Market Analysis, by Product, 2014 - 2026 (USD Million)

  • 5.1 Definition & Scope
  • 5.2 Regional Market Snapshot
  • 5.3 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025
  • 5.4 North America
    • 5.4.1 North America Market Estimates And Forecast, By Country, 2014 - 2026 (USD Million)
    • 5.4.2 U.S.
      • 5.4.2.1 U.S. CRM Devices market, 2014 - 2026 (USD Million)
    • 5.4.3 Canada
      • 5.4.3.1 Canada CRM Devices market, 2014 - 2026 (USD Million)
  • 5.5 Europe
    • 5.5.1 Europe CRM Devices Market, By Country, 2014 - 2026 (USD Million)
    • 5.5.2 UK
      • 5.5.2.1 UK CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.5.3 Germany
      • 5.5.3.1 Germany CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.5.4 France
      • 5.5.4.1 France CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.5.5 Italy
      • 5.5.5.1 Italy CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.5.6 Spain
      • 5.5.6.1 Spain CRM Devices Market, 2014 - 2026 (USD Million)
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific CRM Devices Market, By Country, 2014 - 2026 (USD Million)
    • 5.6.2 Japan
      • 5.6.2.1 Japan Implantation CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.6.3 China
      • 5.6.3.1 China CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.6.4 Australia
      • 5.6.4.1 Australia CRM Devices Market, 2014 - 2026 (USD Million)
    • 5.6.5 India
      • 5.6.5.1 India CRM Devices Market, 2014 - 2026 (USD Million)
  • 5.7 Latin America
    • 5.7.1 Latin America CRM Devices Market, By Country, 2014 - 2026 (USD Million)
    • 5.7.2 Brazil
      • 5.7.2.1 Brazil CRM Devices market, 2014 - 2026 (USD Million)
    • 5.7.3 Mexico
      • 5.7.3.1 Mexico CRM Devices market, 2014 - 2026 (USD Million)
  • 5.8 MEA
    • 5.8.1 Mea CRM Devices Market, By Country2014 - 2026 (USD Million)
    • 5.8.2 South Africa
      • 5.8.2.1 South Africa CRM Devices market, 2014 - 2026 (USD Million)
    • 5.8.3 Saudi Arabia
      • 5.8.3.1 Saudi Arabia CRM Devices market, 2014 - 2026 (USD Million)

Chapter 6 CRM Devices Market - Competitive Analysis

  • 6.1 Company Profiles
  • 6.2 Physio-Control, Inc. (Stryker)
    • 6.2.1 Company Overview
    • 6.2.2 Financial Performance
    • 6.2.3 Product Benchmarking
    • 6.2.4 Strategic Initiatives
  • 6.3 Schiller
    • 6.3.1 Company Overview
    • 6.3.2 Product Benchmarking
    • 6.3.3 Strategic Initiatives
  • 6.4 Medtronic
    • 6.4.1 Company Overview
    • 6.4.2 Financial Performance
    • 6.4.3 Product Benchmarking
    • 6.4.4 Strategic Initiatives
  • 6.5 St Jude Medical (Abbott)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Performance
    • 6.5.3 Product Benchmarking
    • 6.5.4 Strategic Initiatives
  • 6.6 Boston Scientific Corporation
    • 6.6.1 Company Overview
    • 6.6.2 Financial Performance
    • 6.6.3 Product Benchmarking
    • 6.6.4 Strategic Initiatives
  • 6.7 Koninklijke Philips N.V.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Performance
    • 6.7.3 Product Benchmarking
    • 6.7.4 Strategic Initiatives
  • 6.8 Zoll Medical Corporation
    • 6.8.1 Company Overview
    • 6.8.2 Product Benchmarking
    • 6.8.3 Strategic Initiatives
  • 6.9 BIOTRONIK
    • 6.9.1 Company Overview
    • 6.9.2 Product Benchmarking
    • 6.9.3 Strategic Initiatives
Back to Top